Has Lech Dabrowski received payments from drug or device companies?

Yes. Drug and device makers reported $13,279 in general payments to Lech Dabrowski across 381 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Lech Dabrowski did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Lech Dabrowski come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Lech Dabrowski

Hematology & Oncology · Brooklyn, NYNPI 1780798553

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $10,255 of the $13,279 with a category attached, or 77.2%. It is spread thinly across 51 manufacturers, the largest accounting for just 16.1% — the pattern of someone who eats at a lot of different presentations.

$13,279in general payments, 2019–2025

Across 381 payments — averaging $34.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Global Blood Therapeutics, Inc.$2K
Johnson & Johnson$1K
Novartis$1K
E.r. Squibb & Sons, L.L.C.$886
Merck$726
Astellas Pharma US Inc$626
plus $6K from 45 others

What the payments were for

Consulting fees$2,07016%
Food & beverage$10,25577%
Education$9547%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Global Blood Therapeutics, Inc.	4	$2,139
Johnson & Johnson(2 entities)	34	$1,410
Novartis	50	$1,040
E.r. Squibb & Sons, L.L.C.	24	$886
Merck	30	$726
Astellas Pharma US Inc	14	$626
Lilly USA, LLC	21	$552
Amgen(2 entities)	16	$502
Bristol Myers Squibb	12	$466
Incyte Corporation	14	$399
Pharmacyclics LLC, An Abbvie Company	6	$344
Sanofi	12	$334
Daiichi Sankyo Inc.	15	$325
Genentech USA, Inc.	3	$320
Pfizer	14	$315
AstraZeneca(2 entities)	10	$278
Puma Biotechnology, Inc.	13	$262
Rigel Pharmaceuticals, Inc.	7	$233
Tesaro, Inc.	7	$206
Takeda Pharmaceuticals U.S.A., Inc.	9	$196
Blueprint Medicines Corporation	3	$166
Eisai Inc.	8	$160
Dova Pharmaceuticals	2	$126
Pharmacosmos Therapeutics Inc.	1	$123
EMD Serono, Inc.	4	$120
Sobi, Inc	1	$116
Seagen Inc.	6	$110
Sanofi-aventis U.S. LLC	1	$82
Gilead(2 entities)	4	$77
Array Biopharma Inc	3	$50
Foundation Medicine, Inc.	3	$45
Boehringer Ingelheim	2	$44
Karyopharm Therapeutics Inc.	2	$42
Verastem, Inc.	2	$39
Regeneron Healthcare Solutions, Inc.	2	$39
Coherus Oncology, Inc.	2	$39
Janssen Scientific Affairs, LLC	4	$34
Spectrum Pharmaceuticals Inc.	1	$33
Bayer	2	$30
GSK	1	$29
CTI Biopharma Corp.	1	$26
Organon	2	$26
Adaptive Biotechnologies Corporation	1	$21
Epizyme, Inc.	1	$20
Shire North American Group Inc	1	$20
Kyowa Kirin, Inc.	1	$20
Exelixis Inc.	1	$19
Tersera Therapeutics LLC	1	$17
G1 Therapeutics, Inc.	1	$17
Myovant Sciences Inc.	1	$16
AVEO Pharmaceuticals, Inc.	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,279 in reported general payments places this provider in the 75th percentile of 967 hematology & oncology providers in New York.

See all hematology & oncology providers in New York →

Other hematology & oncology in Brooklyn

Perry CookBrooklyn$803K
Ilya BlokhBrooklyn$220K
Yiwu HuangBrooklyn$220K
Songchuan GuoBrooklyn$129K
Michael SchusterNew York$1.6M
Charles SawyersNew York$1.6M
Manuel Hidalgo-MedinaNew York$1.4M
Francis ArenaLake Success$1M
Sanjeev JainEast Patchogue$971K
Ross LevineNew York$968K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →